Alzheimer’s Disease: Many Failures Before One Success
The Long Road To The First Disease-Modifying Alzheimer’s Drug
For Biogen/Eisai’s success with Aduhelm, there were 93 failures in the anti-amyloid field. In Vivo's sister publication Scrip took a look back at how the pipeline for amyloid-targeting Alzheimer’s drugs progressed over the past decade to showcase exactly how difficult the Alzheimer’s space has been.
